image
Healthcare - Medical - Healthcare Plans - NYSE - US
$ 400.69
-1.56 %
$ 92.9 B
Market Cap
14.58
P/E
1. INTRINSIC VALUE

Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.[ Read More ]

The intrinsic value of one ELV stock under the base case scenario is HIDDEN Compared to the current market price of 401 USD, Elevance Health Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart ELV

image
FINANCIALS
171 B REVENUE
9.42%
134 B OPERATING INCOME
1485.14%
5.99 B NET INCOME
-0.47%
8.06 B OPERATING CASH FLOW
-4.02%
-5.57 B INVESTING CASH FLOW
-22.19%
-3.35 B FINANCING CASH FLOW
-154.10%
45.1 B REVENUE
3.43%
1.71 B OPERATING INCOME
-43.42%
1.01 B NET INCOME
-56.17%
2.68 B OPERATING CASH FLOW
498.88%
-401 M INVESTING CASH FLOW
50.98%
-915 M FINANCING CASH FLOW
-136.98%
Balance Sheet Decomposition Elevance Health Inc.
image
Current Assets 60 B
Cash & Short-Term Investments 6.53 B
Receivables 9.96 B
Other Current Assets 43.5 B
Non-Current Assets 48.9 B
Long-Term Investments 30.7 B
PP&E 4.36 B
Other Non-Current Assets 13.8 B
Current Liabilities 41.8 B
Accounts Payable 23 B
Short-Term Debt 1.87 B
Other Current Liabilities 16.9 B
Non-Current Liabilities 27.7 B
Long-Term Debt 23.2 B
Other Non-Current Liabilities 4.49 B
EFFICIENCY
Earnings Waterfall Elevance Health Inc.
image
Revenue 171 B
Cost Of Revenue 124 B
Gross Profit 47 B
Operating Expenses 36.2 B
Operating Income 134 B
Other Expenses 128 B
Net Income 5.99 B
RATIOS
27.44% GROSS MARGIN
27.44%
78.18% OPERATING MARGIN
78.18%
3.49% NET MARGIN
3.49%
15.23% ROE
15.23%
5.50% ROA
5.50%
161.46% ROIC
161.46%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Elevance Health Inc.
image
Net Income 5.99 B
Depreciation & Amortization 1.74 B
Capital Expenditures -1.3 B
Stock-Based Compensation 289 M
Change in Working Capital -535 M
Others -1 B
Free Cash Flow 6.76 B
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Elevance Health Inc.
image
Wall Street analysts predict an average 1-year price target for ELV of $577 , with forecasts ranging from a low of $478 to a high of $649 .
ELV Lowest Price Target Wall Street Target
478 USD 19.29%
ELV Average Price Target Wall Street Target
577 USD 43.98%
ELV Highest Price Target Wall Street Target
649 USD 61.97%
4. DIVIDEND ANALYSIS
0.31% DIVIDEND YIELD
1.63 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership Elevance Health Inc.
image
Sold
0-3 MONTHS
3.21 M USD 1
3-6 MONTHS
17.6 M USD 3
6-9 MONTHS
23.1 M USD 4
9-12 MONTHS
3.54 M USD 3
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
1 month ago
Oct 18, 2024
Sell 3.21 M USD
Kendrick Charles Morgan JR
EVP & President, Commercial
- 7417
432.14 USD
3 months ago
Aug 05, 2024
Sell 400 K USD
PERU RAMIRO G
Director
- 753
531.52 USD
3 months ago
Jul 22, 2024
Sell 548 K USD
BOUDREAUX GAIL
President and CEO
- 1100
498.5 USD
3 months ago
Jul 22, 2024
Sell 10.4 M USD
BOUDREAUX GAIL
President and CEO
- 20779
500.36 USD
3 months ago
Jul 22, 2024
Sell 3.32 M USD
BOUDREAUX GAIL
President and CEO
- 6621
501.4 USD
3 months ago
Jul 22, 2024
Sell 1.13 M USD
BOUDREAUX GAIL
President and CEO
- 2250
502.23 USD
3 months ago
Jul 22, 2024
Sell 504 K USD
BOUDREAUX GAIL
President and CEO
- 1000
503.67 USD
3 months ago
Jul 22, 2024
Sell 1.13 M USD
BOUDREAUX GAIL
President and CEO
- 2250
504.27 USD
3 months ago
Jul 19, 2024
Sell 155 K USD
Dixon Robert L JR
Director
- 305
506.76 USD
6 months ago
Apr 23, 2024
Sell 7.48 M USD
Norwood Felicia F
EVP & President,Gov Health Ben
- 14011
533.73 USD
6 months ago
Apr 23, 2024
Sell 53.5 K USD
Norwood Felicia F
EVP & President,Gov Health Ben
- 100
534.74 USD
6 months ago
Apr 24, 2024
Sell 1.47 M USD
Norwood Felicia F
EVP & President,Gov Health Ben
- 2765
532.14 USD
6 months ago
Apr 24, 2024
Sell 1.83 M USD
Norwood Felicia F
EVP & President,Gov Health Ben
- 3434
532.68 USD
8 months ago
Mar 08, 2024
Sell 1.22 M USD
Kendrick Charles Morgan JR
EVP & President, Commercial
- 2432
500.46 USD
8 months ago
Mar 06, 2024
Sell 462 K USD
Penczek Ronald W
CAO & Controller
- 916
504.58 USD
8 months ago
Mar 04, 2024
Sell 2.1 M USD
Haytaian Peter D
EVP & Pres Carelon & CarelonRx
- 4206
500.18 USD
8 months ago
Mar 04, 2024
Sell 945 K USD
Haytaian Peter D
EVP & Pres Carelon & CarelonRx
- 1889
500.18 USD
8 months ago
Mar 04, 2024
Sell 7.5 M USD
Haytaian Peter D
EVP & Pres Carelon & CarelonRx
- 15000
500.18 USD
9 months ago
Feb 07, 2024
Sell 376 K USD
PERU RAMIRO G
Director
- 753
500 USD
11 months ago
Dec 14, 2023
Sell 2.66 M USD
Todt Blair Williams
EVP, CLO & CAO
- 5492
484.02 USD
11 months ago
Nov 30, 2023
Sell 501 K USD
Penczek Ronald W
CAO & Controller
- 1055
475.17 USD
1 year ago
Oct 24, 2023
Sell 29.1 K USD
Penczek Ronald W
CAO & Controller
- 64
454.35 USD
1 year ago
Jul 21, 2023
Sell 148 K USD
Dixon Robert L JR
Director
- 310
476.71 USD
1 year ago
Mar 24, 2023
Sell 264 K USD
MCCARTHY GLORIA M
EVP & Chief Administrative Off
- 600
440.78 USD
1 year ago
Mar 24, 2023
Sell 221 K USD
MCCARTHY GLORIA M
EVP & Chief Administrative Off
- 500
442.02 USD
1 year ago
Mar 24, 2023
Sell 798 K USD
MCCARTHY GLORIA M
EVP & Chief Administrative Off
- 1800
443.27 USD
1 year ago
Mar 24, 2023
Sell 1.33 M USD
MCCARTHY GLORIA M
EVP & Chief Administrative Off
- 3000
444.33 USD
1 year ago
Mar 24, 2023
Sell 2.48 M USD
MCCARTHY GLORIA M
EVP & Chief Administrative Off
- 5573
445.3 USD
1 year ago
Mar 24, 2023
Sell 1.62 M USD
MCCARTHY GLORIA M
EVP & Chief Administrative Off
- 3625
446.06 USD
1 year ago
Mar 09, 2023
Sell 1.07 M USD
Kendrick Charles Morgan JR
EVP & President, Commercial
- 2314
462.22 USD
2 years ago
Jun 09, 2022
Sell 256 K USD
Kendrick Charles Morgan JR
EVP & President, Commercial
- 522
490.83 USD
2 years ago
Jun 06, 2022
Sell 209 K USD
Dixon Robert L JR
Director
- 420
497.14 USD
2 years ago
Jun 06, 2022
Sell 209 K USD
Dixon Robert L JR
director:
- 420
497.14 USD
2 years ago
May 19, 2022
Sell 464 K USD
PERU RAMIRO G
Director
- 990
468.88 USD
2 years ago
May 18, 2022
Sell 464 K USD
PERU RAMIRO G
director:
- 990
468.88 USD
2 years ago
Mar 10, 2022
Sell 995 K USD
Haytaian Peter D
EVP & Pres., DBG & IngenioRx
- 2170
458.68 USD
2 years ago
Mar 10, 2022
Sell 995 K USD
Haytaian Peter D
EVP & Pres., DBG & IngenioRx
- 2170
458.68 USD
2 years ago
Mar 10, 2022
Sell 1.96 M USD
Haytaian Peter D
EVP & Pres., DBG & IngenioRx
- 4274
459.75 USD
2 years ago
Mar 10, 2022
Sell 1.89 M USD
Haytaian Peter D
EVP & Pres., DBG & IngenioRx
- 4105
460.68 USD
2 years ago
Mar 10, 2022
Sell 2.71 M USD
Haytaian Peter D
EVP & Pres., DBG & IngenioRx
- 5874
461.72 USD
2 years ago
Mar 10, 2022
Sell 574 K USD
Haytaian Peter D
EVP & Pres., DBG & IngenioRx
- 1240
462.73 USD
2 years ago
Mar 10, 2022
Sell 18.5 K USD
Haytaian Peter D
EVP & Pres., DBG & IngenioRx
- 40
463.4 USD
2 years ago
Mar 03, 2022
Sell 1.12 M USD
Penczek Ronald W
CAO & Controller
- 2423
463.68 USD
2 years ago
Feb 07, 2022
Sell 1.25 M USD
Penczek Ronald W
CAO & Controller
- 2763
453.48 USD
3 years ago
Oct 28, 2021
Sell 501 K USD
Penczek Ronald W
SVP, Chief Accounting Officer
- 1150
436 USD
3 years ago
Jul 23, 2021
Bought 500 K USD
Schneider Ryan M.
Director
+ 1300
384.36 USD
3 years ago
May 24, 2021
Sell 521 K USD
PERU RAMIRO G
Director
- 1308
398.02 USD
3 years ago
May 24, 2021
Sell 7.01 M USD
Gallina John E
EVP & Chief Financial Officer
- 17819
393.56 USD
3 years ago
May 24, 2021
Sell 3.22 M USD
Gallina John E
EVP & Chief Financial Officer
- 8163
394.62 USD
3 years ago
May 24, 2021
Sell 6.04 M USD
Gallina John E
EVP & Chief Financial Officer
- 15262
395.67 USD
3 years ago
May 24, 2021
Sell 436 K USD
Gallina John E
EVP & Chief Financial Officer
- 1100
396.5 USD
3 years ago
May 24, 2021
Sell 1.63 M USD
Gallina John E
EVP & Chief Financial Officer
- 4100
397.91 USD
3 years ago
May 20, 2021
Sell 515 K USD
HILL JULIE A
Director
- 1308
394 USD
3 years ago
May 21, 2021
Sell 232 K USD
Dixon Robert L JR
Director
- 590
392.87 USD
6 years ago
Oct 31, 2018
Sell 270 K USD
Haytaian Peter D
EVP & President, Commercial
- 1000
270 USD
3 years ago
Mar 22, 2021
Sell 104 K USD
Haytaian Peter D
EVP & President, Commercial
- 300
345.59 USD
3 years ago
Mar 22, 2021
Sell 3.26 M USD
Haytaian Peter D
EVP & President, Commercial
- 9387
347.44 USD
3 years ago
Mar 22, 2021
Sell 4.33 M USD
Haytaian Peter D
EVP & President, Commercial
- 12416
348.52 USD
3 years ago
Mar 22, 2021
Sell 9.36 M USD
Haytaian Peter D
EVP & President, Commercial
- 26777
349.53 USD
3 years ago
Mar 22, 2021
Sell 2.76 M USD
Haytaian Peter D
EVP & President, Commercial
- 7891
350.21 USD
3 years ago
Mar 22, 2021
Sell 141 K USD
Haytaian Peter D
EVP & President, Commercial
- 400
351.32 USD
3 years ago
Mar 22, 2021
Sell 822 K USD
Haytaian Peter D
EVP & President, Commercial
- 2329
352.84 USD
3 years ago
Mar 05, 2021
Sell 691 K USD
Penczek Ronald W
SVP, Chief Accounting Officer
- 2068
333.94 USD
3 years ago
Mar 04, 2021
Sell 21.7 K USD
Penczek Ronald W
SVP, Chief Accounting Officer
- 67
323.56 USD
3 years ago
Feb 04, 2021
Bought 503 K USD
Schneider Ryan M.
Director
+ 1700
296.03 USD
3 years ago
Dec 15, 2020
Sell 592 K USD
Haytaian Peter D
EVP & President, Commercial
- 1897
312.01 USD
3 years ago
Dec 15, 2020
Sell 1.2 M USD
Haytaian Peter D
EVP & President, Commercial
- 3836
312.76 USD
3 years ago
Dec 15, 2020
Sell 31.3 K USD
Haytaian Peter D
EVP & President, Commercial
- 100
313.42 USD
4 years ago
Nov 16, 2020
Sell 334 K USD
Haytaian Peter D
EVP & President, Commercial
- 1010
330.77 USD
4 years ago
Nov 16, 2020
Sell 133 K USD
Haytaian Peter D
EVP & President, Commercial
- 400
331.92 USD
4 years ago
Nov 16, 2020
Sell 352 K USD
Haytaian Peter D
EVP & President, Commercial
- 1056
332.86 USD
4 years ago
Nov 16, 2020
Sell 401 K USD
Haytaian Peter D
EVP & President, Commercial
- 1200
333.97 USD
4 years ago
Nov 16, 2020
Sell 399 K USD
Haytaian Peter D
EVP & President, Commercial
- 1193
334.87 USD
4 years ago
Nov 16, 2020
Sell 227 K USD
Haytaian Peter D
EVP & President, Commercial
- 675
335.92 USD
4 years ago
Nov 16, 2020
Sell 101 K USD
Haytaian Peter D
EVP & President, Commercial
- 300
337 USD
4 years ago
Nov 09, 2020
Sell 397 K USD
Penczek Ronald W
SVP, Chief Accounting Officer
- 1199
330.75 USD
4 years ago
Nov 03, 2020
Sell 1.4 M USD
ZIELINSKI THOMAS C
EVP & General Counsel
- 4780
292.07 USD
4 years ago
Nov 03, 2020
Sell 585 USD
ZIELINSKI THOMAS C
EVP & General Counsel
- 2
292.64 USD
4 years ago
Nov 03, 2020
Sell 731 K USD
ZIELINSKI THOMAS C
EVP & General Counsel
- 2500
292.35 USD
4 years ago
Nov 03, 2020
Sell 553 K USD
ZIELINSKI THOMAS C
EVP & General Counsel
- 1893
292.32 USD
4 years ago
Oct 15, 2020
Sell 288 K USD
Haytaian Peter D
EVP & President, Commercial
- 1000
287.58 USD
4 years ago
Oct 15, 2020
Sell 232 K USD
Haytaian Peter D
EVP & President, Commercial
- 800
290.3 USD
4 years ago
Oct 15, 2020
Sell 467 K USD
Haytaian Peter D
EVP & President, Commercial
- 1600
292.13 USD
4 years ago
Oct 15, 2020
Sell 329 K USD
Haytaian Peter D
EVP & President, Commercial
- 1120
293.33 USD
4 years ago
Oct 15, 2020
Sell 43.2 K USD
Haytaian Peter D
EVP & President, Commercial
- 147
293.98 USD
4 years ago
Oct 15, 2020
Sell 344 K USD
Haytaian Peter D
EVP & President, Commercial
- 1167
295 USD
4 years ago
Oct 09, 2020
Sell 344 K USD
Haytaian Peter D
EVP & President, Commercial
- 1167
295 USD
4 years ago
Oct 02, 2020
Sell 1.31 M USD
Haytaian Peter D
EVP & President, Commercial
- 4667
280 USD
4 years ago
Jun 08, 2020
Sell 162 K USD
Penczek Ronald W
SVP, Chief Accounting Officer
- 545
297.74 USD
4 years ago
Jun 08, 2020
Sell 331 K USD
PERU RAMIRO G
Director
- 1102
300 USD
4 years ago
Jun 08, 2020
Sell 1.89 M USD
ZIELINSKI THOMAS C
EVP & General Counsel
- 6358
297.7 USD
4 years ago
Jun 08, 2020
Sell 4.2 M USD
Haytaian Peter D
EVP & President, Commercial
- 14001
300 USD
4 years ago
May 27, 2020
Sell 314 K USD
Dixon Robert L JR
Director
- 1102
284.59 USD
4 years ago
May 19, 2020
Sell 312 K USD
HILL JULIE A
Director
- 1102
283.26 USD
4 years ago
May 15, 2020
Sell 434 K USD
MCCARTHY GLORIA M
EVP & Chief Administrative Off
- 1601
271.09 USD
4 years ago
May 15, 2020
Sell 231 K USD
MCCARTHY GLORIA M
EVP & Chief Administrative Off
- 845
272.91 USD
4 years ago
May 15, 2020
Sell 27.3 K USD
MCCARTHY GLORIA M
EVP & Chief Administrative Off
- 100
273.31 USD
4 years ago
May 15, 2020
Sell 440 K USD
MCCARTHY GLORIA M
EVP & Chief Administrative Off
- 1600
275 USD
4 years ago
May 15, 2020
Sell 1.38 M USD
MCCARTHY GLORIA M
EVP & Chief Administrative Off
- 5013
276.11 USD
4 years ago
May 15, 2020
Sell 1.66 M USD
MCCARTHY GLORIA M
EVP & Chief Administrative Off
- 5983
277.02 USD
4 years ago
May 15, 2020
Sell 655 K USD
MCCARTHY GLORIA M
EVP & Chief Administrative Off
- 2356
278.22 USD
4 years ago
May 15, 2020
Sell 213 K USD
MCCARTHY GLORIA M
EVP & Chief Administrative Off
- 763
279.18 USD
4 years ago
Apr 30, 2020
Sell 1.24 M USD
ZIELINSKI THOMAS C
EVP & General Counsel
- 4445
278.9 USD
4 years ago
Apr 30, 2020
Sell 4.13 M USD
ZIELINSKI THOMAS C
EVP & General Counsel
- 14861
278.17 USD
4 years ago
Apr 16, 2020
Sell 4.56 M USD
MCCARTHY GLORIA M
EVP & Chief Administrative Off
- 16884
270 USD
4 years ago
Jan 30, 2020
Bought 528 K USD
BOUDREAUX GAIL
President and CEO
+ 2000
264.22 USD
4 years ago
Jan 30, 2020
Bought 1.48 M USD
BOUDREAUX GAIL
President and CEO
+ 5600
263.52 USD
4 years ago
Dec 20, 2019
Sell 1.26 M USD
Haytaian Peter D
EVP & President, Commercial
- 4167
303.32 USD
4 years ago
Dec 24, 2019
Sell 1.27 M USD
Haytaian Peter D
EVP & President, Commercial
- 4166
303.82 USD
4 years ago
Dec 04, 2019
Sell 3.06 M USD
ZIELINSKI THOMAS C
EVP & General Counsel
- 10600
288.33 USD
5 years ago
Nov 18, 2019
Sell 3.63 M USD
Haytaian Peter D
EVP & President, Commercial
- 12095
300 USD
5 years ago
Nov 12, 2019
Sell 101 K USD
Penczek Ronald W
SVP, Chief Accounting Officer
- 357
282 USD
5 years ago
Nov 13, 2019
Sell 234 K USD
Penczek Ronald W
SVP, Chief Accounting Officer
- 816
287 USD
5 years ago
Oct 28, 2019
Sell 1.27 M USD
Haytaian Peter D
EVP & President, Commercial
- 4713
269.08 USD
5 years ago
Oct 28, 2019
Sell 1.32 M USD
Haytaian Peter D
EVP & President, Commercial
- 4873
270.05 USD
5 years ago
Jul 26, 2019
Sell 489 K USD
HILL JULIE A
Director
- 1656
295 USD
5 years ago
Jul 26, 2019
Sell 153 K USD
Dixon Robert L JR
Director
- 520
294.11 USD
5 years ago
Jun 11, 2019
Sell 2.51 M USD
ZIELINSKI THOMAS C
EVP & General Counsel
- 8826
283.92 USD
5 years ago
May 30, 2019
Sell 213 K USD
Penczek Ronald W
SVP, Chief Accounting Officer
- 763
279 USD
5 years ago
May 21, 2019
Sell 455 K USD
PERU RAMIRO G
Director
- 1656
275 USD
5 years ago
Mar 04, 2019
Sell 150 K USD
MCCARTHY GLORIA M
EVP & Chief Administrative Off
- 500
300.12 USD
5 years ago
Mar 04, 2019
Sell 151 K USD
MCCARTHY GLORIA M
EVP & Chief Administrative Off
- 500
301.46 USD
5 years ago
Mar 04, 2019
Sell 756 K USD
MCCARTHY GLORIA M
EVP & Chief Administrative Off
- 2500
302.32 USD
5 years ago
Mar 04, 2019
Sell 455 K USD
MCCARTHY GLORIA M
EVP & Chief Administrative Off
- 1500
303.22 USD
5 years ago
Mar 04, 2019
Sell 182 K USD
MCCARTHY GLORIA M
EVP & Chief Administrative Off
- 600
304.09 USD
5 years ago
Mar 04, 2019
Sell 337 K USD
MCCARTHY GLORIA M
EVP & Chief Administrative Off
- 1101
306.32 USD
5 years ago
Mar 04, 2019
Sell 185 K USD
MCCARTHY GLORIA M
EVP & Chief Administrative Off
- 600
307.54 USD
5 years ago
Mar 04, 2019
Sell 123 K USD
MCCARTHY GLORIA M
EVP & Chief Administrative Off
- 400
308.35 USD
5 years ago
Feb 04, 2019
Sell 574 K USD
MCCARTHY GLORIA M
EVP & Chief Administrative Off
- 1900
301.85 USD
5 years ago
Feb 04, 2019
Sell 850 K USD
MCCARTHY GLORIA M
EVP & Chief Administrative Off
- 2808
302.84 USD
5 years ago
Feb 04, 2019
Sell 909 K USD
MCCARTHY GLORIA M
EVP & Chief Administrative Off
- 2992
303.82 USD
5 years ago
Jan 31, 2019
Sell 150 K USD
HILL JULIE A
Director
- 500
299.75 USD
5 years ago
Jan 18, 2019
Sell 2.04 M USD
MCCARTHY GLORIA M
EVP & Chief Administrative Off
- 7700
265 USD
5 years ago
Dec 27, 2018
Sell 255 K USD
Haytaian Peter D
EVP & President, Commercial
- 1000
255.03 USD
5 years ago
Dec 27, 2018
Sell 514 K USD
Haytaian Peter D
EVP & President, Commercial
- 2000
256.95 USD
5 years ago
Nov 27, 2018
Sell 194 K USD
Haytaian Peter D
EVP & President, Commercial
- 700
277.29 USD
5 years ago
Nov 27, 2018
Sell 696 K USD
Haytaian Peter D
EVP & President, Commercial
- 2500
278.22 USD
5 years ago
Nov 27, 2018
Sell 251 K USD
Haytaian Peter D
EVP & President, Commercial
- 900
279.3 USD
5 years ago
Nov 27, 2018
Sell 112 K USD
Haytaian Peter D
EVP & President, Commercial
- 400
280.35 USD
6 years ago
Nov 08, 2018
Sell 144 K USD
HILL JULIE A
Director
- 500
287.25 USD
6 years ago
Nov 07, 2018
Sell 2.27 M USD
ZIELINSKI THOMAS C
EVP & General Counsel
- 7826
289.71 USD
6 years ago
Oct 26, 2018
Sell 802 K USD
Haytaian Peter D
EVP & President, Commercial
- 3000
267.34 USD
6 years ago
Oct 26, 2018
Sell 135 K USD
Haytaian Peter D
EVP & President, Commercial
- 500
269.1 USD
6 years ago
Sep 27, 2018
Sell 1.22 M USD
Haytaian Peter D
EVP & President, Commercial
- 4500
270 USD
6 years ago
Sep 06, 2018
Sell 523 K USD
Haytaian Peter D
EVP & President, Commercial
- 1936
270 USD
6 years ago
Sep 06, 2018
Sell 270 K USD
Haytaian Peter D
EVP & President, Commercial
- 1000
270 USD
7. News
Elevance Health, Inc. (ELV) UBS Global Healthcare Conference (Transcript) Elevance Health, Inc. (NYSE:ELV ) UBS Global Healthcare Conference November 12, 2024 10:15 AM ET Company Participants Mark Kaye - Executive VP & CFO Conference Call Participants A.J. Rice - UBS A.J. seekingalpha.com - 1 day ago
Elevance Health Declines 20% in 3 Months: Time to Sell the Stock? ELV encounters headwinds such as higher benefit costs, an increased debt level and member attrition in the Medicaid business, which raise concerns among investors. zacks.com - 4 days ago
Elevance Health, Inc. Shareholders are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses SAN DIEGO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether Elevance Health, Inc. (NYSE: ELV) or any of its executive officers or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focuses on investors' losses and whether they may be recovered under federal securities laws. globenewswire.com - 1 week ago
Elevance Health Announces Appearance at UBS Global Healthcare Conference INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) announced today that senior management is scheduled to present at the UBS Global Healthcare Conference in Rancho Palos Verdes, California on November 12, at 7:15 a.m. Pacific Standard Time (PST) / 10:15 a.m. Eastern Standard Time (EST). All interested parties are invited to listen to a live webcast of the presentation by visiting www.elevancehealth.com and selecting the “Investors” link. You may also access the link here. For those unab. businesswire.com - 1 week ago
My Top 15 High-Growth Dividend Stocks For November 2024 The SPDR S&P 500 ETF Trust posted a loss of 0.89% in October, putting a pause on its strong run in 2024. The Top 15 dividend growth stocks for November 2024 offer an average dividend yield of 1.24% and appear to be about 23% undervalued based on dividend yield theory. Since its inception in September 2020, the watch list has achieved an 11.33% compound annual growth rate. seekingalpha.com - 1 week ago
Elevance Health Foundation Names Professional Football Player Ryan Kelly as Next Elevance Health Champion INDIANAPOLIS--(BUSINESS WIRE)-- #maternalhealth--The Elevance Health Foundation, the philanthropic arm of Elevance Health, today announces professional football player Ryan Kelly as its latest Elevance Health Champion. Designed to help increase awareness for critical health challenges and raise funds for local organizations that are making a healthy difference in their communities, the Elevance Health Champion program recognizes professional athletes and organizations who have dedicated their life to leading hea. businesswire.com - 2 weeks ago
AM Best Assigns Issue Credit Ratings to Elevance Health, Inc. New Senior Unsecured Bonds OLDWICK, N.J.--(BUSINESS WIRE)--AM Best has assigned a Long-Term Issue Credit Rating of “bbb+” (Good) to Elevance Health, Inc.'s (Elevance Health) (Indianapolis, IN) newly issued $350 million, 4.5% senior unsecured bonds, due 2026; $750 million, 4.750% senior unsecured bonds, due 2030; $750 million, 4.95% senior unsecured bonds, due 2031; $1.2 billion, 5.2% senior unsecured bonds, due 2035; $1.35 billion, 5.7% senior unsecured bonds, due 2055; and $800 million, 5.85% senior unsecured bonds, due. businesswire.com - 3 weeks ago
'Overuse' is causing healthcare insurer headwinds, says Mizuho's Jared Holz Jared Holz, Mizuho healthcare equity strategist, joins CNBC's 'The Exchange' to discuss why healthcare insurer stocks are down, whether weight loss drugs have any impact, and more. youtube.com - 3 weeks ago
What's Behind The 15% Fall For Elevance Health Stock? Elevance Health (NYSE: ELV) recently reported its Q3 results, with revenues exceeding but earnings missing the consensus estimates. The company reported revenue of $44.7 billion and adjusted earnings of $8.37 per share, compared to the street estimates of $43.5 billion and $9.66, respectively. forbes.com - 3 weeks ago
Elevance Health Stock: Looking Beyond Near-Term Issues, I'm A Buyer Elevance Health's Q3 2024 results were disappointing with a significant increase in the benefit expense ratio and lowered earnings expectations for the full year. I take a close look at ELV's exposure to government plans and their profitability. I explain why I view Elevance stock as favorably valued even under very conservative near and long-term growth assumptions. seekingalpha.com - 4 weeks ago
These Analysts Cut Their Forecasts On Elevance Health Following Q3 Earnings Elevance Health Inc. ELV reported weaker-than-expected earnings for its third quarter on Thursday. benzinga.com - 4 weeks ago
Elevance Health: Why Invest Over UnitedHealth Group? Despite a disappointing Q3 report, Elevance Health remains attractive due to its relatively favorable valuation compared to UnitedHealth Group and a total shareholder yield of roughly 3.5%. Elevance's expansion into healthcare services through Carelon and continued strength in Medicare and Medicaid markets support long-term growth, especially given the industry's demographic tailwinds. Though 2024 is a “reset” year, Elevance management's outlook for 2025 and beyond points to strong potential margin recovery and continued earnings growth. seekingalpha.com - 4 weeks ago
8. Profile Summary

Elevance Health Inc. ELV

image
COUNTRY US
INDUSTRY Medical - Healthcare Plans
MARKET CAP $ 92.9 B
Dividend Yield 0.31%
Description Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Contact 220 Virginia Avenue, Indianapolis, IN, 46204 https://www.elevancehealth.com
IPO Date Oct. 30, 2001
Employees 104900
Officers Ms. Julie Goon Senior Vice President of Public Affairs Mr. Peter David Haytaian Esq. Executive Vice President and President of Carelon & CarelonRx Ms. Gail Koziara Boudreaux President, Chief Executive Officer & Director Mr. Blair Williams Todt Executive Vice President and Chief Legal & Administrative Officer Ms. Felicia Farr Norwood Executive Vice President & President of Government Health Benefits Mr. Scott Wayne Anglin SVice President, Treasurer & Chief Investment Officer Mr. Ronald William Penczek Senior Vice President, Controller & Chief Accounting Officer Mr. Stephen Vartan Tanal C.F.A. Vice President of Investor Relations Mr. Kyle Weber Chief Strategy Officer & Interim Chief Marketing Officer Mr. Mark Bradley Kaye Executive Vice President & Chief Financial Officer